Advanced Search

Home > Journals > Minerva Endocrinologica > Archive > Minerva Endocrinologica 2013 March;38(1) > Minerva Endocrinologica 2013 March;38(1):47-58

CURRENT ISSUE   ARCHIVE   EPUB AHEAD OF PRINT   MOST READ


MINERVA ENDOCRINOLOGICA

Minerva Endocrinologica 2013 March;38(1):47-58

CLINICAL ENDOCRINOLOGY 

Bariatric surgery for type 2 diabetes: to whom and when?

Samaras K.

Department of Endocrinology St Vincent’s Hospital, Diabetes and Obesity Group, Garvan Institute of Medical Research, Sydney, Australia

Achieving clinical and biochemical targets in type 2 diabetes mellitus (diabetes) is fundamental to preventing diabetic microvascular and macrovascular complications. These clinical imperatives are made more challenging in the setting of obesity. This review examines the evidence for bariatric surgery as a means of optimizing diabetes care, addressing diabetes resolution, glucose and lipid metabolism and cardiac effects. Mechanistic evidence of diabetes amelioration is summarized. The question of when bariatric surgery should be offered in the course of obesity-associated diabetes is discussed. Current guidelines and specialist society recommendations for bariatric surgery in diabetes are summarized.

language: English


FULL TEXT  REPRINTS

top of page